Solara Active Pharma Sciences Ltd: Stock Analysis & Fundamentals

Updated this week

Solara Active Pharma Sciences Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. ROE: 0.1%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

💪Debt reduced 19% YoY — balance sheet strengthening

👔Promoter buying — stake up 4.7% this quarter

🌐FII stake decreased 0.7% this quarter

Key Numbers

Current Price

₹443

Market Cap

2.0K Cr

Valuation

N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd

Average

+15.9%

Acutaas Chemicals Ltd

SMS Pharmaceuticals Ltd

Average • 12w streak

+37.7%

← Back to Pharma - API & CRAMS Dashboard

Frequently Asked Questions: Solara Active Pharma Sciences Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Solara Active Pharma Sciences Ltd's latest quarterly results?

Solara Active Pharma Sciences Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -312.5%
Revenue Growth YoY: +16.3%
Operating Margin: 11.0%

What is Solara Active Pharma Sciences Ltd's price-to-book ratio?

Solara Active Pharma Sciences Ltd's price-to-book ratio is 1.3x.

Price-to-Book (P/B): 1.3x
Book Value per Share: ₹347
Current Price: ₹443

Is Solara Active Pharma Sciences Ltd a fundamentally strong company?

Solara Active Pharma Sciences Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 6.0%

Is Solara Active Pharma Sciences Ltd debt free?

Solara Active Pharma Sciences Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹796 Cr

What is Solara Active Pharma Sciences Ltd's return on equity (ROE) and ROCE?

Solara Active Pharma Sciences Ltd's return ratios over recent years

FY2023: ROCE 2.0%
FY2024: ROCE -9.0%
FY2025: ROCE 6.0%

Is Solara Active Pharma Sciences Ltd's cash flow positive?

Solara Active Pharma Sciences Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹213 Cr
Free Cash Flow (FCF): ₹176 Cr
CFO/PAT Ratio: 21300% (strong cash conversion)

What is Solara Active Pharma Sciences Ltd's dividend yield?

Solara Active Pharma Sciences Ltd currently does not pay a significant dividend (yield 0.00%).

Dividend Yield: 0.00%
Current Price: ₹443

Who holds Solara Active Pharma Sciences Ltd shares — promoters, FII, DII?

Solara Active Pharma Sciences Ltd's shareholding pattern (Dec 2025)

Promoters: 42.0%
FII (Foreign): 12.0%
DII (Domestic): 3.6%
Public: 42.4%

Is promoter holding increasing or decreasing in Solara Active Pharma Sciences Ltd?

Solara Active Pharma Sciences Ltd's promoter holding has decreased recently.

Current Promoter Holding: 42.0% (Dec 2025)
Previous Quarter: 42.0% (Sep 2025)
Change: -0.01% (decreasing — worth monitoring)

Is Solara Active Pharma Sciences Ltd a new momentum entry or an established outperformer?

Solara Active Pharma Sciences Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Solara Active Pharma Sciences Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Solara Active Pharma Sciences Ltd may be worth studying

Cash flow is positive — CFO ₹213 Cr

What is the investment thesis for Solara Active Pharma Sciences Ltd?

Solara Active Pharma Sciences Ltd investment thesis summary:

What is the future outlook for Solara Active Pharma Sciences Ltd?

Solara Active Pharma Sciences Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.